Avery AJ - Search Results

1

A comparison of the performance of the EQ-5D and SF-6D for individuals aged >or= 45 years.

Barton GR, Sach TH, Avery AJ, Jenkinson C, Doherty M, Whynes DK, Muir KR. Barton GR, et al. Among authors: avery aj. Health Econ. 2008 Jul;17(7):815-32. doi: 10.1002/hec.1298. Health Econ. 2008. PMID: 17893863

2

Prescribing cost savings by GP fundholders: long-term or short-term?

Whynes DK, Heron T, Avery AJ. Whynes DK, et al. Among authors: avery aj. Health Econ. 1997 Mar-Apr;6(2):209-11. doi: 10.1002/(sici)1099-1050(199703)6:2<209::aid-hec263>3.0.co;2-b. Health Econ. 1997. PMID: 9158972

3

Controlled trial of pharmacist intervention in general practice: the effect on prescribing costs.

Rodgers S, Avery AJ, Meechan D, Briant S, Geraghty M, Doran K, Whynes DK. Rodgers S, et al. Among authors: avery aj. Br J Gen Pract. 1999 Sep;49(446):717-20. Br J Gen Pract. 1999. PMID: 10756613 Free PMC article. Clinical Trial.

4

A prescription for improvement? An observational study to identify how general practices vary in their growth in prescribing costs.

Avery AJ, Rodgers S, Heron T, Crombie R, Whynes D, Pringle M, Baines D, Petchey R. Avery AJ, et al. BMJ. 2000 Jul 29;321(7256):276-81. doi: 10.1136/bmj.321.7256.276. BMJ. 2000. PMID: 10915132 Free PMC article.

5

The relationship between body mass index and health-related quality of life: comparing the EQ-5D, EuroQol VAS and SF-6D.

Sach TH, Barton GR, Doherty M, Muir KR, Jenkinson C, Avery AJ. Sach TH, et al. Among authors: avery aj. Int J Obes (Lond). 2007 Jan;31(1):189-96. doi: 10.1038/sj.ijo.0803365. Epub 2006 May 9. Int J Obes (Lond). 2007. PMID: 16682976

6

Accounting for the increase in NSAID expenditure: substitution or leakage?

Barton GR, Avery AJ, Whynes DK. Barton GR, et al. Among authors: avery aj. Cost Eff Resour Alloc. 2006 May 31;4:9. doi: 10.1186/1478-7547-4-9. Cost Eff Resour Alloc. 2006. PMID: 16737538 Free PMC article.

7

An assessment of the discriminative ability of the EQ-5Dindex, SF-6D, and EQ VAS, using sociodemographic factors and clinical conditions.

Barton GR, Sach TH, Doherty M, Avery AJ, Jenkinson C, Muir KR. Barton GR, et al. Among authors: avery aj. Eur J Health Econ. 2008 Aug;9(3):237-49. doi: 10.1007/s10198-007-0068-z. Epub 2007 Jun 29. Eur J Health Econ. 2008. PMID: 17605057

8

Do estimates of cost-utility based on the EQ-5D differ from those based on the mapping of utility scores?

Barton GR, Sach TH, Jenkinson C, Avery AJ, Doherty M, Muir KR. Barton GR, et al. Among authors: avery aj. Health Qual Life Outcomes. 2008 Jul 14;6:51. doi: 10.1186/1477-7525-6-51. Health Qual Life Outcomes. 2008. PMID: 18625052 Free PMC article. Clinical Trial.

9

Comparing cost-utility estimates: does the choice of EQ-5D or SF-6D matter?

Sach TH, Barton GR, Jenkinson C, Doherty M, Avery AJ, Muir KR. Sach TH, et al. Among authors: avery aj. Med Care. 2009 Aug;47(8):889-94. doi: 10.1097/MLR.0b013e3181a39428. Med Care. 2009. PMID: 19584759 Clinical Trial.

10

Comparing the performance of the EQ-5D and SF-6D when measuring the benefits of alleviating knee pain.

Barton GR, Sach TH, Avery AJ, Doherty M, Jenkinson C, Muir KR. Barton GR, et al. Among authors: avery aj. Cost Eff Resour Alloc. 2009 Jul 17;7:12. doi: 10.1186/1478-7547-7-12. Cost Eff Resour Alloc. 2009. PMID: 19615052 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

253 results

Search Page

Filters